Sanofi Appoints Belén Garijo as CEO, Signaling Bold Leadership Shift to Strengthen Innovation and Performance

Belén Garijo to become Chief Executive Officer of Sanofi Sanofi's Board of Directors met on February 11, 2026, and decided not to renew the Direc...

February 13, 2026 | Friday | News
CEO Daniel O’Day Underscores Strength of Gilead’s HIV Franchise After Solid 2025 Results

  Product Sales Excluding Veklury Increased 4% Year-Over-Year to $28.0 billion for Full Year 2025 Biktarvy Sales Increased 7% Year-Over-Year to $1...

February 12, 2026 | Thursday | Company results
Eccogene Reports Positive Phase 1b Results for Oral GLP-1 Candidate Elecoglipron in China

Elecoglipron demonstrated a favorable safety and tolerability profile in Chinese adults living with obesity/overweight with or without type 2 diabete...

February 12, 2026 | Thursday | News
Geneoscopy Strengthens Diagnostic Market Position After USPTO Invalidates Exact Sciences Patent Claims

Decision removes last patent hurdle as Geneoscopy advances ColoSense®, its RNA-based noninvasive colorectal cancer screening test Geneosco...

February 09, 2026 | Monday | News
Genentech Advances Regulatory Path for Fenebrutinib After Phase III Success in Progressive MS

– Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority co...

February 09, 2026 | Monday | News
QIAGEN CEO Thierry Bernard Highlights Resilient Growth as 2025 Results Beat Outlook and Set Strong 2026 Trajectory

Q4 2025: Net sales of $540 million (+4% at actual rates, +1% at constant exchange rates (CER)); diluted EPS of $0.49 and adjusted diluted EPS of $0.6...

February 06, 2026 | Friday | Company results
From Symptoms to Systems: The Rise of Multiomics in Disease Research

  In this BioPharma Boardroom interview, Jason Causon, Senior Technical Product Manager for Accurate Mass Platforms at SCIEX, explores how multiomi...

February 04, 2026 | Wednesday | Interaction
From Injections to Pills: How Mass Spectrometry Is Reshaping Biopharma

  Drug delivery is entering a period of rapid reinvention, driven as much by analytical innovation as by molecular design. In this BioPharma BoardRoo...

February 04, 2026 | Wednesday | Interaction
mRNA’s Next Act: Why Analytical Science Matters More Than Ever

As mRNA technologies move rapidly beyond COVID-19 into vaccines and therapies for cancer, rare diseases, and personalized medicine, scientific complexity i...

February 04, 2026 | Wednesday | Interaction
Automation, SPE, and Mass Spectrometry: The New Front Line of PFAS Regulation

As regulators worldwide intensify scrutiny of per- and polyfluoroalkyl substances (PFAS), laboratories are being pushed into a new era of sensitivity, sp...

February 04, 2026 | Wednesday | Interaction
Pfizer CEO Albert Bourla Signals Confidence in 2026 as Company Delivers Solid 2025 Results

Dr. Albert Bourla, Chairman and CEO of Pfizer, said: “With excellent execution in 2025, we delivered a solid financial performance and strengt...

February 05, 2026 | Thursday | Company results
Sartorius CEO Dr Michael Grosse Reports Strong 2025 Performance As Group Revenue Climbs To €3.5 Billion

  Preliminary results for 2025: Group sales revenue rises by 7.6 percent to around 3.5 billion euros Positive development in both divi...

February 04, 2026 | Wednesday | Company results
SEQSTER and Praxis Expand Collaboration to Accelerate CNS Clinical Development

Multi-study collaboration leverages SEQSTER's real world data (RWD) platform to support Praxis's portfolio of precision therapies for CNS disorders ...

February 04, 2026 | Wednesday | News
insitro Uncovers Novel Peripheral Obesity Target Through AI-Enabled Brown Fat Genetics

AI-enabled brown adipose tissue (BAT) phenotype unlocks population-scale human genetic discovery BAT-01 knockdown drives 15% body-weight reduction in ...

February 04, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close